Oleanolic Acid‐Enriched Olive Oil Attenuates Kidney Function Decline in Patients With Type 2 Diabetes: Results From the OLTRAD Randomised Controlled Trial
- Autores
- Aída García‐González, Alejandro Matamoros-Domínguez, Juan Manuel Espinosa-Cabello y otros 12
- Publicado
- Diabetes Obesity and Metabolism · 17 ago 2026
- DOI
- 10.1111/dom.71206
- Acceso
- abierto
Resumen de los autores
AIMS: Chronic kidney disease (CKD) is a major complication of type 2 diabetes mellitus (T2DM), driven in part by oxidative stress and the accumulation of advanced glycation end products (AGEs). Oleanolic acid (OA), a natural triterpene present in olive-derived matrices, may modulate AGE metabolism. In this prespecified, exploratory secondary analysis of the OLTRAD trial, we evaluated whether long-term intake of OA-enriched olive oil attenuates kidney function decline in patients with T2DM. METHODS: In the OLTRAD randomised controlled trial, 97 patients with T2DM were assigned to consume…
Lo enlaza: Xataka